CRHR2 and irritable bowel syndrome: In a recent report on the lack of a CRF1r antagonist efficacy to ameliorate colonic symptoms in IBS patients 29, it has been suggested that impairment in the CRF1r‐CRF2r integrated response might be implicated in the pathogenesis of this disease.